Provider Reviews

Vaylen vs Hers: Compounded GLP-1 vs FDA-Approved Wegovy

Quick verdict: Vaylen is a cash-pay platform focused on compounded GLP-1s with lower prepaid 12-month rates and a prepay then clinician review model; Hers focuses on FDA-approved Wegovy with a membership requirement and personalized dose check-ins.

See Vaylen pricing and formats

This article compares Vaylen vs Hers across the most distinctive differences: regulatory status of medications, price and payment model, medication formats and molecule options, and care model and membership requirements. The goal is to help you choose based only on the supplied facts.

Vaylen vs Hers: Regulatory status and medication type

Vaylen offers compounded semaglutide and tirzepatide in injectable and oral formats. Vaylen states that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Hers offers FDA-approved Wegovy, explicitly stating it is not a compounded product and highlighting FDA-approved brand-name options such as Wegovy and Zepbound where applicable.

Price, billing cadence, and payment model

Vaylen publishes annualized low rates that require prepaying a 12-month plan in one charge. Example headline rates are semaglutide from $83.25/mo on the 12-month plan or $224/mo month to month, oral semaglutide $99/mo prepaid or $249/mo monthly, and tirzepatide $149/mo prepaid or $299/mo monthly. Vaylen is clear that every 12-month rate is billed upfront and you pay before a clinician review, with a full refund if the clinician declines to prescribe.

Hers lists Wegovy from $149/mo and injectable options from $199/mo, but medication requires an active Hers Weight Loss Membership. The membership is required to access medication and is billed separately. The membership pricing examples include $39 for the first month and auto-renewal at $149/mo thereafter in the captured landing-page evidence. Hers states medication and membership are billed separately and a prescription is not guaranteed.

Compare Vaylen prepurchase terms

Medication formats and molecule options

Vaylen supports three formats and two molecules on one platform: once weekly semaglutide injections, daily oral semaglutide tablets, and once weekly tirzepatide injections. Vaylen emphasizes both molecules and a needle-free tablet option so a clinician can switch formats without changing providers.

Hers focuses on FDA-approved Wegovy as a brand-name semaglutide product and also references other brand-name GLP-1s such as Ozempic and Zepbound as brand options where clinically appropriate. Hers states no compounded medications are offered.

Care model, clinician review, shipping and availability

Vaylen charges a $0 consultation fee and states a board-certified U.S. clinician reviews the health form within 24 hours. Vaylen includes free discreet shipping in 1 to 3 business days and states licensed clinicians are available in all 50 states. Vaylen also states a full refund if the clinician declines to prescribe for that billing cycle.

Hers highlights a personalized care team with ongoing dose check-ins and notes that medication is subject to clinician determination and state availability. Hers also cautions that some brand medications are available only to patients who meet clinical eligibility criteria and that services may not be available in all 50 states.

Five-criterion comparison table

Criteria Vaylen Hers
Regulatory status Compounded medications, not FDA-approved FDA-approved Wegovy, not compounded
Starting price cited Semaglutide from $83.25/mo on 12-month plan Wegovy from $149/mo
Payment model Prepay 12-month plans billed upfront; full refund if not approved Membership required; medication and membership billed separately
Medication formats Weekly injections, daily oral tablet, tirzepatide injections Brand-name Wegovy and other FDA-approved options where eligible
Clinician review and support $0 consultation fee, clinician review within 24 hours, shipping in 1 to 3 days Personalized care team with ongoing dose check-ins; prescription not guaranteed

See Hers Wegovy membership details

How the prepay versus membership choice affects users

Vaylen requires payment before clinician review, with Vaylen stating a full refund if a clinician declines to prescribe for that billing cycle. That prepay model is positioned as a way to access lower annualized rates. Hers requires an active membership to access medication and separates membership and medication charges, which Hers states may be $39 for the first month and auto-renew at $149/mo thereafter in captured examples.

Review Hers membership and medication terms

Conclusion: Vaylen vs Hers and final guidance

Vaylen vs Hers hinges on whether you prioritize lower prepaid prices and compounded options or FDA approval and a membership-based, brand-name plan. Vaylen offers lower headline prepaid rates and multiple formats of compounded GLP-1 on one platform, with a clinician review within 24 hours and a stated refund if not approved. Hers offers FDA-approved Wegovy with a personalized care team and ongoing dose check-ins but requires an active membership and notes medication is not guaranteed.

Choose Vaylen if you want a cash-pay compounded GLP-1 platform with the lowest effective monthly prepaid rates, multiple formats including oral tablets, clinician review within 24 hours, free discreet shipping in 1 to 3 business days, and a stated full refund if a clinician declines to prescribe.

Choose Hers if you want FDA-approved, brand-name Wegovy and a personalized care team with ongoing dose check-ins and understand that medication access requires an active membership and clinician eligibility.

Ready to Compare Telehealth Providers?

Explore leading providers β€” physician-supervised, all-inclusive pricing, and free home delivery.

Compare All Providers β†’

Related articles

Medical disclaimer: This page is for informational purposes only and is not medical advice. Always consult a licensed healthcare provider before starting any treatment. We may earn a commission from partner links on this page - see our advertising disclosure.